GLP1R and type 2 diabetes mellitus: In line with these findings, the dual GIP/GLP-1 RA, tirzepatide, was found to delay gastric emptying in T2D, with evidence that this effect may be diminished after 23 days of treatment (ie, suggestive of tachyphylaxis) (Table 2) (117).